跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 144,804 条关于
“BAFF-R CAR T-cell therapy”
全部
144,804
临床试验
108,456
药物
10,074
机构
935
资讯
25,339
去年
PeproMene Bio Secures $11 Million Investment to Advance BAFF-R CAR T-Cell Therapy for Follicular Lymphoma
10天前
PeproMene Bio's BAFF-R CAR T-Cell Therapy Shows 80% Complete Response Rate in Relapsed/Refractory B-Cell Lymphomas
去年
Novel BAFF-R CAR-T Therapy Achieves Complete Response in Heavily Pretreated Follicular Lymphoma Patient
9天前
Lancet Publishes Phase 1 Data for PeproMene's BAFF-R CAR T: 80% Complete Response, Grade 1-Only Toxicity
3个月前
PeproMene Bio's BAFF-R CAR-T Therapy Shows 78% Complete Response Rate in B-Cell Lymphoma Patients After CD19 CAR-T Failure
去年
FDA Approves Autolus' CAR-T Cell Therapy Aucatzyl for Relapsed/Refractory B-ALL
去年
CAR T-Cell Therapy Demonstrates Efficacy and Manageable Safety in Relapsed/Refractory Mantle Cell Lymphoma
2年前
PeproMene Bio's BAFFR-CAR T Cell Therapy Shows Promise in Relapsed B-ALL Trial
10个月前
PeproMene Bio's BAFFR-CAR T Therapy Shows Promising Results in Relapsed B-Cell Cancers
去年
FDA Approves Obe-Cel for Adult R/R ALL, Marking a Significant Advance in CAR T-Cell Therapy
第 1 页,共 2534 页
上一页
下一页